» Articles » PMID: 11334968

Development of a Novel Flow Cytometric Cell-mediated Cytotoxicity Assay Using the Fluorophores PKH-26 and TO-PRO-3 Iodide

Overview
Publisher Elsevier
Date 2001 May 4
PMID 11334968
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

A flow cytometric (FCM) assay has been developed for the determination of cell-mediated cytotoxicity (CMC). In the assay, the target tumour cell population was labelled with a membrane dye, PKH-26, prior to incubation with splenocyte effector cells. Cell death within the target population was assessed by the addition of the viability probe TO-PRO-3 iodide (TP3) and analysed by flow cytometry. The extent of cytotoxicity was determined by the relative number of live target cells labelled with PKH-26 only and dead, permeabilised cells labelled with both PKH-26 and TP3. This CMC method allows the analysis to be conducted on a single cell basis and overcomes the need for radiochemicals. This communication indicates that the FCM assay is an accurate and reproducible experimental system capable of analysing natural killer (NK) cell and antibody-dependent cell-mediated cytotoxicity. The procedure is comparable to the chromium release assay. We believe that this is one of the first demonstrations of an FCM-based antibody-dependent cell-mediated cytotoxicity (ADCC) assay.

Citing Articles

A novel method to assess antibody-dependent cell-mediated cytotoxicity against influenza A virus M2 in immunized murine models.

Liang Y, Guo J, Li Z, Liu S, Zhang T, Sun S Biosaf Health. 2025; 6(3):178-185.

PMID: 40078727 PMC: 11895015. DOI: 10.1016/j.bsheal.2024.04.002.


An Overview of the Current State of Cell Viability Assessment Methods Using OECD Classification.

Madorran E, Ambroz M, Knez J, Sobocan M Int J Mol Sci. 2025; 26(1.

PMID: 39796074 PMC: 11719996. DOI: 10.3390/ijms26010220.


CD34DNAM-1CXCR4 haemopoietic precursors circulate after chemotherapy, seed lung tissue and generate functional innate-like T cells and NK cells.

Perrone C, Bozzano F, Dal Bello M, Del Zotto G, Antonini F, Munari E Front Immunol. 2024; 15:1332781.

PMID: 38390333 PMC: 10881815. DOI: 10.3389/fimmu.2024.1332781.


Reduced frequency of cytotoxic CD56 CD16 NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma.

Panisova E, Lunemann A, Burgler S, Kotur M, Lazarovici J, Danu A Cancer Immunol Immunother. 2021; 71(1):13-24.

PMID: 33993319 PMC: 8738354. DOI: 10.1007/s00262-021-02956-x.


ablation with CRISPR/Cas9 enhances cytotoxicity of human placental stem cell-derived NK cells for cancer immunotherapy.

Guo X, Mahlakoiv T, Ye Q, Somanchi S, He S, Rana H J Immunother Cancer. 2021; 9(3).

PMID: 33741730 PMC: 7986888. DOI: 10.1136/jitc-2020-001975.